Every round on record, with the sources behind each and the investors on them.
A startup focused on precision therapies for autoimmune and inflammatory diseases
beelinemedicines.comLinkedInBoston, USABiotechFounded 2025
6 sources
The company release and Torys state a $126.3 million Series A extension announced on June 30, 2026; the roundup gives the rounded amount as 126 million dollars and places the item in the June 29–July 2 week. No source calls any investor a lead, so all named investors are listed as participants.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A ext. Series A extension [ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $126M | 2026-06-30 | not stated | No recent discussion |
6 sources [ VERIFIED · CORRECTED ] read against 6 sources
The company release and Torys state a $126.3 million Series A extension announced on June 30, 2026; the roundup gives the rounded amount as 126 million dollars and places the item in the June 29–July 2 week. No source calls any investor a lead, so all named investors are listed as participants. | ||||
Checked against 10 sources on Sep 24